ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Thiophenol → 2-(p-Nitrophenylthio)ethyl 2,3,4,6-tetra-O-acetyl-beta-D-galactopyranoside

HRID 653326
ノート
印刷プレビュー

反応式

HRID 653326 の反応式
[N+:1]([C:4]1[CH:9]=[CH:8][C:7]([SH:10])=[CH:6][CH:5]=1)([O-:3])=[O:2].[H-].[Na+].[C:13]([O:16][C@@H:17]1[C@@H:26]([O:27][C:28](=[O:30])[CH3:29])[C@@H:25]([O:31][C:32](=[O:34])[CH3:33])[C@@H:24]([CH2:35][O:36][C:37](=[O:39])[CH3:38])[O:23][C@H:18]1[O:19][CH2:20][CH2:21]Br)(=[O:15])[CH3:14].C1(S)C=CC=CC=1>CN(C)C=O.CCOCC.C(OCC)(=O)C.C(CC(C)(C)C)(C)C>[C:13]([O:16][C@@H:17]1[C@@H:26]([O:27][C:28](=[O:30])[CH3:29])[C@@H:25]([O:31][C:32](=[O:34])[CH3:33])[C@@H:24]([CH2:35][O:36][C:37](=[O:39])[CH3:38])[O:23][C@H:18]1[O:19][CH2:20][CH2:21][S:10][C:7]1[CH:8]=[CH:9][C:4]([N+:1]([O-:3])=[O:2])=[CH:5][CH:6]=1)(=[O:15])[CH3:14]
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 7969ThiophenolHCID 158094-NitrobenzenethiolHCID 24758Sodium hydrideHCID 105757262-bromoethyl 2,3,4,6-tetra-O-acetyl-beta-D-galactopyranoside

生成物 1

HCID 545191362-(p-Nitrophenylthio)ethyl 2,3,4,6-tetra-O-acetyl-beta-D-galactopyranoside

試薬・触媒・溶媒 3

HCID 3283
Diethyl Ether
溶媒
HCID 6228Dimethylformamide溶媒2 回
HCID 18516502EtOAc isooctane溶媒

実験手順

p-Nitrothiophenol (50 mg; 0.32 mmol) was added to a suspension of sodium hydride (oil-free; 11 mg; 0.46 mmol) in dimethylformamide (3 ml) at room temperature and with stirring. 2-Bromoethyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (1) (110 mg; 0.24 mmol) in dimethylformamide (3 ml) was added during 10 min to the thiophenol solution and the reaction mixture was stirred for another 75 min (TLC: SiO2, ethyl acetate:isooctane 1:1). The reaction mixture was poured into ice-cold water (20 ml) and ether (40 ml). The aqueous phase was extracted further with ether (40 ml) and the combined organic phases were washed with cold water (20 ml) and dried (sodium sulfate). Evaporation and chromatography (SiO2, ethyl acetate:isooctane 1:1) gave the title compound (25) as a light yellow oil. Yield: 80 mg (62%). [α]D23 -15.2° (c 1.1; CDCl3); 1H-NMR (CDCl3, TMS) δ 8.14, 7.36 (ABq, 4H, JAB =9.2 Hz, aromatic H), 5.40 (dd, 1H, J4,5 =1.0 Hz, H4), 5.22 (dd, 1H, J2,3 =10.5 Hz, H2), 5.01 (dd, 1H, J3,4 =3.4 Hz, H3), 4.52 (d, 1H, J1,2 =7.8 Hz, H1), 3.25 (t, 2H, J=6.5 Hz, S--CH2), 2.17, 2.05, 2.04, 1.99 (s, 3H each, CH3CO) ppm. 13C-NMR (CDCl3, TMS) δ 170.4, 170.2, 170.1, l69.4 (CO), 146.6, 145.3, 126.5, 124.1 (aromatic C), 101.4 (Cl), 70.9, 70.8, 68.5, 66.9 (C2-C5), 67.9 (CH2 --O) 61.2 (C6), 31.8 (S--CH2), 20.8, 20.7, 20.6 (CH3CO) ppm.

後処理

  1. extractionThe aqueous phase was extracted further with ether (40 ml)
  2. washthe combined organic phases were washed with cold water (20 ml)
  3. dry with materialdried (sodium sulfate)
  4. customEvaporation and chromatography (SiO2, ethyl acetate:isooctane 1:1)

出典と根拠

ORDレコード
ord-a75a6a942fdb47e286f909a18d51a4b0
出典データセット
uspto-grants-1987_06
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US04675392

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート